The chip giant still faces concerns about security flaws in its chips, but strong results overshadow worries.

As junk-bond issuance has surged in Asia, the quality of investor-protecting bond covenants has plunged.

Activist investors who broke up the $15 billion Clariant-Huntsman merger promised a long-term approach to creating value. Three months later, they’ve

General Electric’s new transparency is welcome, but a focus on cash shows that the company is probably no bargain even after its swoon.

It isn’t a happy new year for dollar bulls, with the currency starting 2018 by falling to a three-year low. The weak dollar has consequences elsewhere

Patience from biotechnology investors may be needed this year, but it will be rewarded in the long run.